Literature DB >> 23285700

Methods for methotrexate determination in macromolecular conjugates drug carrier.

Jarosław Ciekot1, Tomasz Goszczyński, Janusz Boratyńskit.   

Abstract

In this paper, two simple, cost-effective and fast methods for quantification of methotrexate (MTX) in the macromolecular conjugates are presented. The method for analysis of total MTX in preparations was based on absorption spectrophotometry. Validation was performed by measuring absorbance at 372 nm of the sodium bicarbonate solution. Curve describing drug concentration against absorption had a linear character in the range of 1.204-40.13 microM. The reproducibility and precision of method was 0.1558 to 3.086%. The recovery of the method was between 99.56 and 104.7%. The limit of quantitation method was 1.050 microM. The method for free MTX determination was based on size exclusion chromatography and UV-VIS detection at the wavelength of 302 nm. Superdex Peptide column (150 x 4.6 mm) and a mobile phase 0.1 M sodium bicarbonate with a flow rate of 0.4 mL/min was used. In the free drug determination method, the curve had a linear character in the range of 2.006-200.6 microM. The reproducibility and precision of method was 0.3761 to 2.452%. The recovery of the method was between 93.18 and 104.5%. The limit of quantitation method was 0.9203 microM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23285700

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  6 in total

1.  Cysteine capped copper/molybdenum bimetallic nanoclusters for fluorometric determination of methotrexate via the inner filter effect.

Authors:  Yowan Nerthigan; Amit Kumar Sharma; Sunil Pandey; Hui-Fen Wu
Journal:  Mikrochim Acta       Date:  2019-02-01       Impact factor: 5.833

2.  Hydroxyethyl starch as an effective methotrexate carrier in anticancer therapy.

Authors:  T M Goszczyński; B Filip-Psurska; K Kempińska; J Wietrzyk; J Boratyński
Journal:  Pharmacol Res Perspect       Date:  2014-05-06

3.  An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma.

Authors:  Marta Lisowska; Magdalena Milczarek; Jarosław Ciekot; Justyna Kutkowska; Wojciech Hildebrand; Andrzej Rapak; Arkadiusz Miazek
Journal:  Cancers (Basel)       Date:  2019-09-26       Impact factor: 6.639

4.  Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell‑based vaccines in murine colon carcinoma.

Authors:  Agnieszka Szczygieł; Natalia Anger-Góra; Katarzyna Węgierek-Ciura; Jagoda Mierzejewska; Joanna Rossowska; Tomasz M Goszczyński; Marta Świtalska; Elżbieta Pajtasz-Piasecka
Journal:  Oncol Rep       Date:  2021-01-11       Impact factor: 3.906

Review 5.  Analytical methodologies for determination of methotrexate and its metabolites in pharmaceutical, biological and environmental samples.

Authors:  Forough Karami; Sara Ranjbar; Younes Ghasemi; Manica Negahdaripour
Journal:  J Pharm Anal       Date:  2019-06-20

6.  Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy.

Authors:  Jarosław Ciekot; Mateusz Psurski; Katarzyna Jurec; Janusz Boratyński
Journal:  Invest New Drugs       Date:  2020-07-08       Impact factor: 3.850

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.